Karissa Emerson, NP
Nurse Practitioner · Fargo, NDNPI 1912490830
Payments from drug & device makers
Across 58 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$100
- Boston Scientific$60
- Pfizer$47
- GSK$47
- Novartis$45
- Astellas Pharma US Inc$41
- plus $590 from 29 others
What the payments were for
- Food & beverage$930100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $100 |
| Boston Scientific | 2 | $60 |
| Pfizer | 3 | $47 |
| GSK | 3 | $47 |
| Novartis | 3 | $45 |
| Astellas Pharma US Inc | 2 | $41 |
| AstraZeneca | 3 | $40 |
| Merck | 2 | $37 |
| Dexcom, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Baxter Healthcare | 2 | $32 |
| Mylan Specialty L.p. | 2 | $30 |
| Amgen | 2 | $30 |
| Lundbeck LLC | 2 | $29 |
| Bayer | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Viiv Healthcare Company | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
| Radius Health, Inc. | 1 | $11 |
How this compares
$930 in reported general payments places this provider in the 80th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $79,003 |
| EliquisApixaban | 84 | $73,275 |
| MounjaroTirzepatide | 41 | $43,084 |
| JardianceEmpagliflozin | 21 | $20,557 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $15,766 |
| TrulicityDulaglutide | 16 | $15,309 |
| LinzessLinaclotide | 23 | $13,513 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $11,415 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $8,947 |
| MyrbetriqMirabegron | 12 | $8,727 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $8,372 |
| JanuviaSitagliptin Phosphate | 11 | $6,110 |
| Duloxetine Hcl | 71 | $5,124 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 22 | $4,911 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $2,757 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $13 | $79,00374 claims |
| PfizerEliquis | $47 | $73,27584 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humulin N | $17 | $59,01170 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Shingrix | $47 | $29,04966 claims |
| AbbVieLinzess | $100 | $13,51323 claims |
| Astellas Pharma US IncMyrbetriq | $41 | $8,72712 claims |
| MerckJanuvia | $37 | $6,11011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Fargo
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Andrea HansonFargo$5K
- Leah WoldenFargo$3K
- Richard SchueFargo$2K
- Tyroniesha ReedFargo$2K
- Roberta StigenFargo$2K
- Haley FisherFargo$2K
- Jessie PeckaFargo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.